Bids Are Invited For Select The Proposal Capable Of Generating The Most Advantageous Result For The Acquisition Of Pharmacological Material To Meet The Demand Of The Uepg Hospital Complex.

(L1) 6501.212-Acebrophylline, 10 Mg/Ml (Adult), Syrup, Bottle, 120 Ml, Dosing Cup/Syringe, Route Of Administration: Oral, Units. Size: Unit, (L2) 6501.220-Acyclovir Sodium, 250 Mg, Powder For Injection Solution, Vial-Ampule, Route Of Administration: Intravenous, (L3) 6501.261-Amiodarone, Hydrochloride, 50 Mg/Ml, Injectable Solution, Ampoule, 3 Ml, (L4) 6501.288-Betamethasone, Acetate + Betamethasone, Disodium Phosphate, 3 + 3 Mg/Ml, Injectable Suspension, 1 Ml, Route Of Administration: Intramuscular / Intra-Articular / Intralesional / Soft Tissue, (L5) 6502.1031-Carbamazepine, 20 Mg/Ml, Oral Suspension, 100 Ml, Ordinance 344/98: C1, (L6) 6501.508-Clarithromycin, 500 Mg, Coated Tablet, Blister, (L7) 6501.1249-Clopidogrel, Bisulfate, 75 Mg, (L8) 6501.8499-Dexmedetomidine, 100 Mcg/Ml, 2 Ml, (L9) 6501.551-Dextran 70 + Hypromellose, 1 Mg + 3 Mg/Ml, Ophthalmic Solution, Drip Bottle, 15 Ml, Route Of Administration: Ophthalmic, (L10) 6501.2739-Doxazosin, Mesylate, 4Mg, Tablet, (L11) 6502.1107-Phenytoin, 5 Ml, Route Of Administration: Intramuscular/Intravenous, (L12) 6502.1109-Sodium Phenobarbital, 100 Mg/Ml, Ordinance 344/98: B1, (L13) 6502.1124-Fentanyl, Citrate, 0.05 Mg/Ml, Route Of Administration: Intramuscular/Intravenous/Epidural/Intrathecal, Ordinance 344/98: A1, (L14) 6502.1125-Fentanyl, Ampoule/Ampule-Vial, 10 Ml, (L15) 6502.1126-Flumazenil, 1 Mg/Ml, (L16) 6502.1128-Fluoxetine, Drops Solution, 20 Ml, (L17) 6501.3040-Gentamicin, Sulfate, 40 Mg/Ml (80 Mg), (L18) 6502.3691-Haloperidol, 5 Mg/Ml, Route Of Administration: Intramuscular, (L19) 6501.898-Lactulose, 667 Mg/Ml, Dosing Cup, (L20) 6502.3053-Methadone, 10 Mg/Ml, Route Of Administration: Intramuscular/Subcutaneous, (L21) 6501.840-Metoclopramide, 10 Mg, (L22) 6501.844-Metoclopramide, (L23) 6501.1780-Neostigmine, Methylsulfate, Route Of Administration: Subcutaneous/Intramuscular/Intravenous, (L24) 6501.4794-Nifedipine, (L25) 6501.62424-Nystatin+Zn Oxide, 100000Ui/G+200Mg/G, Ointment, Tube, 60 G, Units. Size: Tube, (L26) 6501.2521-Polymyxin B, Sulfate + Neomycin, Sulfate + Hydrocortisone, 10,000 Iu + 5 Mg + 10 Mg/Ml, Otological Suspension, Route Of Administration: Otological, (L27) 6501.51923-Propylthiouracil, 100Mg, (L28) 6502.3210-Risperidone, Solution, 30 Ml, Dosing Syringe, (L29) 6501.952-Salbutamol, (L30) 6501.1788-Suxamethonium, Chloride, 100 Mg, (L31) 6501.1004-Tobramycin + Dexamethasone, 3 Mg + 1 Mg/G, Ophthalmic Ointment, Tube, 3.5 G, (L32) 6502.30766-Tramadol, Oral Solution, % Accepted Variation (Up) In The Unit Of Measurement Of The Primary Packaging: 50%, Ordinance 344/98: A2, (L33) 6502.1203-Tramadol, 50 Mg/Ml (50 Mg), (L34) 6501.24134-Alprostadil, 20 Mcg, Lyophilized Powder For Injectable Solution, Diluent, Syringe, Route Of Administration: Other Parenteral Routes, Intracavernous, (L35) 6501.100095-Hydrated Sodium Zirconium Cyclosilicate, 5 G, Powder For Solution, Envelope, (L36) 6501.74851-Iodinated Contrast Medium For Blood Tests Lymphography, Sialography, Fistulography And Hysterosalpingography. Ethyl Esters Of Fatty Acids From Iodized Poppy Oil, Iodine Concentration: 480 Mg/Ml, (L37) 6501.49915-Barium Sulfate - Radiological Contrast. Oral Suspension. Concentration: 100% - 1G/Ml, Packaging - Cup With 150Ml Or 200 Ml